ストックスクリーナーアプリを入手
35.53
5.34%
1.80
Moderna Inc (MRNA) 最新ニュース
CIBC Asset Management Inc Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Stock: The Future Unveiled! Innovative Tech to Drive Explosive Growth! - Reporteros del Sur -
Market plunges after new Coronavirus reported in Wuhan but Pfizer and Moderna stock soars - Daily Mail
Why Moderna Inc. (MRNA) Surged On Friday? - Insider Monkey
Moderna (NASDAQ:MRNA) Trading 8.8% HigherWhat's Next? - MarketBeat
Moderna and Other Vaccine Stocks Climb After Coronavirus News From China - MSN
Chinese researchers find bat virus enters human cells via same pathway as COVID -February 21, 2025 at 05:56 pm EST - Marketscreener.com
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China - Yahoo Finance
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - MarketBeat
Moderna (NASDAQ:MRNA) Trading Up 8.8%Time to Buy? - MarketBeat
Moderna (NASDAQ:MRNA) Trading Down 7.9% Following Analyst Downgrade - MarketBeat
Moderna, Novavax rise as new bat coronavirus identified in China - MSN
Moderna stock rises amid new virus concerns By Investing.com - Investing.com Australia
Analyst calls of the week: Rivian, Block, Moderna, Bumble... - Proactive Investors USA
Moderna, Inc. SEC 10-K Report - TradingView
Rx Rundown: Moderna, Sanofi, GSK and more - MM+M Online
Meitav Investment House Ltd. Sells 184,043 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release? - MSN
Moderna, Inc. to Host Earnings Call - ACCESS Newswire
MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Baillie Gifford & Co. Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRNA - ACCESS Newswire
Moderna (NASDAQ:MRNA) Price Target Lowered to $78.00 at UBS Group - MarketBeat
Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion - MSN
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - Nasdaq
Moderna (MRNA) Expected to Announce Earnings on Thursday - MarketBeat
Intrinsic Value Partners LLC Lowers Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna's (MRNA) "Sector Perform" Rating Reiterated at Royal Bank of Canada - MarketBeat
Wall Street Thinks This Beaten-Down Growth Stock Can Soar 85% in 2025. Should You Buy It Now? - MSN
EMA Urged Pfizer And Moderna To Boost Production Volume Of COVID Vax - BW Healthcare World
UBS Adjusts Moderna Price Target to $78 From $96, Maintains Buy Rating -February 19, 2025 at 10:21 am EST - Marketscreener.com
Why Moderna (MRNA) Went Up on Tuesday? - Yahoo Finance
Moderna: A Generational Opportunity for Investors in 2025 - MarketBeat
Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health - Quantisnow
Moderna (NASDAQ:MRNA) Stock Rating Lowered by Barclays - MarketBeat
Moderna price target lowered to $78 from $96 at UBS - TipRanks
Trump’s Hammer Hits FDA, Moderna Falls Further and Patent Cliffs Loom - BioSpace
Barclays Downgrades Moderna (WBAG:MRNA) - Nasdaq
Rep. Julie Johnson Sells Moderna, Inc. (NASDAQ:MRNA) Shares - MarketBeat
Louisiana State Employees Retirement System Sells 30,100 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Q4 2024 Earnings Call Transcript - MSN
Barclays Downgrades Moderna (MRNA) - MSN
Barclays Downgrades Moderna (BIT:1MRNA) - Nasdaq
Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook - GuruFocus.com
Why Moderna (MRNA) Stock Is Up Today By Stock Story - Investing.com Canada
Moderna's Stock Increases by 11.8% Despite Market ChallengesNews and Statistics - IndexBox, Inc.
MRNA: Moderna Stock Rises on Financial Results Despite Downgrade - GuruFocus.com
Moderna rises 8% even as Barclays downgrades - Seeking Alpha
Moderna shares move higher as investors look beyond Q4 losses - Proactive Investors UK
Why Moderna (MRNA) Stock Is Up Today - Financial Content
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges - Benzinga
Moderna has limited upside: Barclays By Investing.com - Investing.com Canada
Barclays Downgrades Moderna (XTRA:0QF) - Nasdaq
Market movers: Intel, Moderna, Aftermath Silver, EnWave... - Proactive Investors USA
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns? - Yahoo
Barclays Downgrades Moderna to Equalweight From Overweight, Adjusts Price Target to $45 From $111 - Marketscreener.com
Moderna’s Financial Challenges and Pipeline Setbacks Prompt ‘Sell’ Rating by Analyst Tim Anderson - TipRanks
Barclays Downgrades Moderna (MRNA) to Equalweight - StreetInsider.com
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):